XBiotech(XBIT)
AUSTIN, TXBiotechnology
Focus: XBiotech is a public biotechnology company focused on antibody-based therapies for immunology and oncology indications. With 5,000+ employees and a market cap-implied scale, the company operates as a clinical-stage developer with multiple programs in early-to-mid development.
Profile data last refreshed 22h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
5000+
Total Funding
$2.5M
Open Jobs
0
About XBiotech
AI assessmentNot HiringNo open roles listed right now. Follow XBiotech to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
8 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
No marketed products
XBiotech is a clinical-stage company with no approved or revenue-generating drugs.
Pipeline & Clinical Trials
Hutrukin
PharmacokineticsClinical Trials (1)
Help build intelligence for XBiotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.